Boston Scientific (BSX) Current Deferred Tax Assets (2009 - 2019)

Boston Scientific has disclosed Current Deferred Tax Assets across 11 years of filings, most recently posting $195.0 million for Q4 2019.

• Current Deferred Tax Assets for Q4 2019 came in at $195.0 million, up 124.14% year-over-year; the trailing twelve-month figure through Dec 2019 was $195.0 million (up 124.14% YoY), and the FY2019 annual result was $195.0 million, up 124.14% from the prior year.
• Current Deferred Tax Assets came in at $195.0 million for Q4 2019 at Boston Scientific, up from $189.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $496.0 million in Q4 2015 to a low of $43.0 million in Q3 2018.
• The 5-year median for Current Deferred Tax Assets is $81.0 million (2016), against an average of $153.0 million.
• Across the five-year window, Current Deferred Tax Assets tumbled 84.88% in 2016 and jumped 339.53% in 2019, its largest moves.
• Boston Scientific's Current Deferred Tax Assets stood at $496.0 million in 2015, then sank by 84.88% to $75.0 million in 2016, then dropped by 12.0% to $66.0 million in 2017, then jumped by 31.82% to $87.0 million in 2018, then surged by 124.14% to $195.0 million in 2019.
• The last three Current Deferred Tax Assets figures came in at $195.0 million (Q4 2019), $189.0 million (Q3 2019), and $175.0 million (Q2 2019), per Business Quant data.